JP Patent

JP2020189882A — Ｍｅｋインヒビターおよびその使用方法

Assigned to Exelixis Inc · Expires 2020-11-26 · 5y expired

What this patent protects

【課題】哺乳動物における過剰増殖性疾患（例えば、癌）の処置において有用なＭＥＫの特定のインヒビターの提供。【解決手段】例えば下記の化合物。【選択図】なし

USPTO Abstract

【課題】哺乳動物における過剰増殖性疾患（例えば、癌）の処置において有用なＭＥＫの特定のインヒビターの提供。【解決手段】例えば下記の化合物。【選択図】なし

Drugs covered by this patent

cobimetinib-fumarate (COBIMETINIB FUMARATE)

Patent Metadata

Patent number: JP2020189882A
Jurisdiction: JP
Classification: —
Expires: 2020-11-26
Drug substance claim: No
Drug product claim: No
Assignee: Exelixis Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.